Tanzania

In Tanzania, the largest country in East Africa, estimated life expectancy is 44 years and falling while the infant mortality rate is 99 per 1,000 and rising. Notably, Tanzania bears a large share of the global HIV/AIDS pandemic; according to the UNAIDS 2006 Report of the Global AIDS Epidemic, an estimated 1.4 million people (6.5% of adults) were living with HIV in 2005. These phenomenae are largely attributable to the national HIV/AIDS infection rate. USAID calculated that, without intervention, there will be approximately 1.8 million AIDS orphans in Tanzania by 2010. Tanzania is one of 15 US President's Emergency Plan Emergence Plan for AIDS Relief (PEPFAR) focus countries receiving support for comprehensive HIV/AIDS prevention, treatment and care programs. (read Tanzania report).  According to a 2012 USAID-issued HIV/AIDS Health Profile for Tanzania, overall HIV prevalence among adults decreased from 7.1 percent in 2001 to 5.6 percent in 2009.  Read full report.

CCGHE RESPONDS

CCGHE currently provides open access to several HIV-related distance learning continuing medical education programs such as Johns Hopkins Infectious Diseases Grand Rounds, which are recorded and archived. Health workers from Tanzania are also tuning into our bi-weekly HIV Clinical Case Discussions. CCGHE has future plans to develop distance education courses that specifically meet the needs of health care providers in Tanzania. 

 

A5273: Multicenter Study of Options for Second-Line Effective Combination Therapy (SELECT)

Post Date: 
2011-05-12
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), a type of anti-HIV drug) but the drugs in this regimen are not doing a good job of fighting their HIV infection. The main purpose of this study...

P1073: Study of Immune Reconstitution Inflammatory Syndrome (IRIS) for International Sites Initiating Highly Active Antiretroviral Therapy (HAART) in Infants and Children < 72 Months of Age

Post Date: 
2010-11-15
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children (≥ 4 weeks to < 72 months of age) at international IMPAACT sites who are within 1 week of HAART initiation and if ≤ 12 months of age have had prior BCG immunization. The...

P1077BF: Breastfeeding Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere)

Post Date: 
2010-02-02
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting Maternal and Infant Survival Everywhere (PROMISE) Protocol is a research protocol of the IMPAACT network designed to address in an integrated and comprehensive fashion...

P1077FF: Formula Feeding Version of the PROMISE Study (Promoting Maternal and Infant Survival Everywhere)

Post Date: 
2010-02-02
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting Maternal and Infant Survival Everywhere (PROMISE) Protocol is a research protocol of the IMPAACT network designed to address in an integrated and comprehensive fashion...

P1060: Phase II, parallel, randomized, clinical trials comparing the responses to initiation of NNRTI-based antiretroviral therapy in HIV-infected infants who have not previously received Single dose Nevirapine for prevention of Mother-to-child HIV...

Post Date: 
2006-03-27
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been shown to be an effective way of reducing the risk of mother-to-child transmission (MTCT) of HIV. The purpose of this study was to compare the effectiveness of a non-...

The Afya Bora Consortium: an Africa-US partnership to train leaders in global health

Post Date: 
2011-06-15
Publication: 
Infectious Disease Clinics of North America
The Afya Bora Consortium is a partnership of eight academic health institutions, four in Africa and four in the United States. The Consortium members have a history of collaboration in four African-U.S. pairs: Makerere University, Kampala, Uganda, and Johns Hopkins University, Baltimore, Maryland,...
Subscribe to RSS - Tanzania